FilingReader Intelligence
SinoMab raises HK$369m through discounted share placement
July 22, 2025 at 02:49 PM UTC•By FilingReader AI
SinoMab BioScience raised HK$369m by issuing 182 million new shares at HK$2.03 each, representing a 16.12% discount to market price.
The new shares represent 15.12% of existing share capital. Proceeds will fund clinical trials, R&D, and working capital through 2027.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:3681•Hong Kong Exchange
News Alerts
Get instant email alerts when SinoMab BioScience publishes news
Free account required • Unsubscribe anytime